flooidCX Corp.

2022 Q3 Form 10-Q Financial Statement

#000147793222005230 Filed on July 20, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $220.00 $1.770K $590.00
YoY Change -68.12% -70.79% -52.8%
Cash & Equivalents $221.00 $1.774K $587.00
Short-Term Investments
Other Short-Term Assets $1.270K $10.30K $7.730K
YoY Change -90.68% -41.04% -0.13%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.491K $12.08K $8.320K
YoY Change -89.58% -48.65% -49.18%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $11.43K $12.20K
YoY Change -100.0% -23.81% -20.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $11.43K $12.20K
YoY Change -100.0% -23.86% -20.87%
TOTAL ASSETS
Total Short-Term Assets $1.491K $12.08K $8.320K
Total Long-Term Assets $0.00 $11.43K $12.20K
Total Assets $1.491K $23.51K $20.52K
YoY Change -94.6% -38.99% -35.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.39K $431.3K $360.9K
YoY Change -94.42% 41.85%
Accrued Expenses $1.158M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.801M $3.534M $3.436M
YoY Change -13.21% 6.49% 9.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.997M $5.273M $5.037M
YoY Change -14.63% 10.83% 15.23%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.997M $5.273M $5.037M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.997M $5.273M $5.037M
YoY Change -14.63% 10.83% 15.23%
SHAREHOLDERS EQUITY
Retained Earnings -$49.22M -$57.21M -$57.00M
YoY Change 1.49%
Common Stock $2.021K $2.021K $2.021K
YoY Change 2.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.995M -$5.249M -$5.017M
YoY Change
Total Liabilities & Shareholders Equity $1.491K $23.51K $20.52K
YoY Change -94.6% -38.99% -35.45%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-280378 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5016957 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23506 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-26037 usd
CY2022Q2 us-gaap Assets
Assets
23506 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-198558 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20515 usd
CY2022Q2 us-gaap Revenues
Revenues
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-232071 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-478936 usd
CY2022Q2 flcx Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.10
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q2 flcx Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.14
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2021Q2 us-gaap Revenues
Revenues
10322 usd
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
35-2511643
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1282A Cornwall Road
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2020871 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2020871 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336309 shares
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-05-31
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Entity File Number
EntityFileNumber
000-55965
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
flooidCX Corp.
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001609988
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Oakville
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2022Q2 dei Entity Address Country
EntityAddressCountry
CA
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L6J 7W5
CY2022Q2 dei City Area Code
CityAreaCode
855
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
535-6643
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2020871 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1774 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10303 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7733 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
12077 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
431333 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
63303 usd
CY2022Q2 us-gaap Loans Payable Current
LoansPayableCurrent
3534011 usd
CY2022Q2 flcx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
2020871 shares
CY2021Q2 flcx Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
1970840 shares
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
289094 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11429 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-201752 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-278772 usd
CY2022Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
4282 usd
CY2021Q2 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1606 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-206034 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5249028 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1307190 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5272534 usd
CY2022Q1 us-gaap Liabilities
Liabilities
5037472 usd
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2020871 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2020871 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
2021 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2021 usd
CY2022Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
19616 usd
CY2022Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
19616 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51875727 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51875727 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
62858 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
88895 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57210250 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57004216 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
127168 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
138449 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
161926 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
201752 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-5016957 usd
CY2022Q2 flcx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-26037 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-206034 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5249028 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-4339988 usd
CY2021Q2 flcx Shares Returned And Cancelled Amount
SharesReturnedAndCancelledAmount
0 usd
CY2021Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
14373 usd
CY2022Q2 flcx Proceeds From Related Party Loans
ProceedsFromRelatedPartyLoans
0 usd
CY2021Q2 flcx Proceeds From Related Party Loans
ProceedsFromRelatedPartyLoans
85070 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83699 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
99443 usd
CY2021Q2 flcx Fair Value Of Shares To Be Issued For Services
FairValueOfSharesToBeIssuedForServices
10355 usd
CY2021Q2 flcx Fair Value Of Stock Options Vested
FairValueOfStockOptionsVested
89887 usd
CY2021Q2 flcx Foreign Exchange Translation Loss
ForeignExchangeTranslationLoss
-198668 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-280378 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4718682 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
206034 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
280378 usd
CY2022Q2 us-gaap Depreciation
Depreciation
810 usd
CY2021Q2 us-gaap Depreciation
Depreciation
1162 usd
CY2022Q2 flcx Financing Costs
FinancingCosts
4282 usd
CY2021Q2 flcx Financing Costs
FinancingCosts
1606 usd
CY2022Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2021Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
10355 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
89887 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7380 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2570 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9727 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
66156 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19715 usd
CY2022Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
61665 usd
CY2021Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
54297 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75691 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-105703 usd
CY2022Q2 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
83699 usd
CY2022Q2 flcx Effect Of Exchange Rate On Cash Equivelent
EffectOfExchangeRateOnCashEquivelent
-6821 usd
CY2021Q2 flcx Effect Of Exchange Rate On Cash Equivelent
EffectOfExchangeRateOnCashEquivelent
11064 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1187 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4804 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
587 usd
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1251 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1774 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6055 usd
CY2022Q2 us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; TEXT-INDENT: 0in; text-align:justify;"><strong>1. </strong><strong>Nature of Operations and Continuance of Business</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">flooidCX Corp. (formerly Gripevine, Inc. and Baixo Relocation Services, Inc.) (the “Company”) was incorporated in the state of Nevada on January 7, 2014. The Company is in the business of developing and building an online resolution platform.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, have adversely affected workforces, economies, and financial markets globally, leading to an economic downturn. The impact on the Company has not been significant, but management continues to monitor the situation.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.25in; text-align:justify;">These condensed consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, creditors, and related parties, and the ability of the Company to obtain necessary equity financing to continue operations, and ultimately the attainment of profitable operations. As at May 31, 2022, the Company has a working capital deficit of $5,260,457 and an accumulated deficit of $57,210,250 since inception. As at May 31, 2022, the Company is in default of certain loans payable (refer to Note 4). Furthermore, during the three months ended May 31, 2022, the Company used $75,691 in operating activities. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p>
CY2022Q2 flcx Working Capital Deficit
WorkingCapitalDeficit
-5260457 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57210250 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75691 usd
CY2022Q2 us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.12 pure
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
68839 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11429 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81353 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
81034 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
69924 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12195 usd
CY2020Q4 flcx Stock Issued For Interest And Late Payment Penalties For The Loan Payable Amount
StockIssuedForInterestAndLatePaymentPenaltiesForTheLoanPayableAmount
25500 usd
CY2020Q4 us-gaap Repayments Of Longterm Loans From Vendors
RepaymentsOfLongtermLoansFromVendors
3984 usd
CY2020Q4 flcx Extension Of The Maturity Date Of The Loan
ExtensionOfTheMaturityDateOfTheLoan
2020-11-25
CY2020Q4 flcx Loss On Settlement Of Debt
LossOnSettlementOfDebt
21516 usd
CY2020Q4 flcx Stock Issued For Interest And Late Payment Penalties For The Loan Payable Share
StockIssuedForInterestAndLatePaymentPenaltiesForTheLoanPayableShare
17648 shares
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1189476 usd
CY2022Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1123076 usd
CY2022Q2 flcx Proceeds From Related Party
ProceedsFromRelatedParty
117714 usd
CY2022 flcx Proceeds From Related Party
ProceedsFromRelatedParty
117491 usd
CY2022Q2 us-gaap Debt Conversion Original Debt Interest Rate Of Debt
DebtConversionOriginalDebtInterestRateOfDebt
0.05 pure
CY2022Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
17.00
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
353956 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.00
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
230781 shares
CY2022Q2 flcx Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledWeightedAverageExercisePrice
17.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
123175 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue
0
CY2022Q2 flcx Range Of Exercise Prices
RangeOfExercisePrices
17.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
123175 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P2Y1M6D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
17.00
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
123175 shares

Files In Submission

Name View Source Status
0001477932-22-005230-index-headers.html Edgar Link pending
0001477932-22-005230-index.html Edgar Link pending
0001477932-22-005230.txt Edgar Link pending
0001477932-22-005230-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
flcx-20220531.xsd Edgar Link pending
flcx-20220531_cal.xml Edgar Link unprocessable
flcx-20220531_def.xml Edgar Link unprocessable
flcx-20220531_lab.xml Edgar Link unprocessable
flcx-20220531_pre.xml Edgar Link unprocessable
flcx_10q.htm Edgar Link pending
flcx_10q_htm.xml Edgar Link completed
flcx_ex311.htm Edgar Link pending
flcx_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending